Serum Institute Awaiting Gavi Push For $2 Pneumococcal Vaccine

Pricing Comes Close To MSF’s $5 A Course Target

 
• By Vibha Ravi
  
Vaccination
Serum First Indian Company To Develop Pneumococcal Vaccine • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip